Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Apyx Medical (APYX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $4.6 million.

  • Apyx Medical's Cost of Revenue rose 103.68% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year decrease of 688.97%. This contributed to the annual value of $18.7 million for FY2024, which is 81.76% up from last year.
  • Apyx Medical's Cost of Revenue amounted to $4.6 million in Q3 2025, which was up 103.68% from $4.3 million recorded in Q2 2025.
  • Apyx Medical's 5-year Cost of Revenue high stood at $5.7 million for Q4 2023, and its period low was $2.8 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $4.3 million (2023), whereas its average is $4.2 million.
  • In the last 5 years, Apyx Medical's Cost of Revenue skyrocketed by 6935.85% in 2021 and then plummeted by 1233.99% in 2025.
  • Quarter analysis of 5 years shows Apyx Medical's Cost of Revenue stood at $4.7 million in 2021, then fell by 6.48% to $4.4 million in 2022, then skyrocketed by 31.19% to $5.7 million in 2023, then fell by 8.29% to $5.3 million in 2024, then dropped by 12.89% to $4.6 million in 2025.
  • Its Cost of Revenue stands at $4.6 million for Q3 2025, versus $4.3 million for Q2 2025 and $3.8 million for Q1 2025.